JP2009528843A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009528843A5 JP2009528843A5 JP2008558377A JP2008558377A JP2009528843A5 JP 2009528843 A5 JP2009528843 A5 JP 2009528843A5 JP 2008558377 A JP2008558377 A JP 2008558377A JP 2008558377 A JP2008558377 A JP 2008558377A JP 2009528843 A5 JP2009528843 A5 JP 2009528843A5
- Authority
- JP
- Japan
- Prior art keywords
- thrombin
- human
- prothrombin
- recombinant human
- hek
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims 11
- 108090000190 Thrombin Proteins 0.000 claims 8
- 108010094028 Prothrombin Proteins 0.000 claims 6
- 102100027378 Prothrombin Human genes 0.000 claims 6
- 229940039716 prothrombin Drugs 0.000 claims 6
- 108010049003 Fibrinogen Proteins 0.000 claims 4
- 102000008946 Fibrinogen Human genes 0.000 claims 4
- 101000651439 Homo sapiens Prothrombin Proteins 0.000 claims 4
- 229940012952 fibrinogen Drugs 0.000 claims 4
- 229940039715 human prothrombin Drugs 0.000 claims 4
- 229960004072 thrombin Drugs 0.000 claims 4
- 229960003766 thrombin (human) Drugs 0.000 claims 4
- 230000037048 polymerization activity Effects 0.000 claims 3
- 108010015680 recombinant human thrombin Proteins 0.000 claims 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 108010085662 ecarin Proteins 0.000 claims 1
- 230000013595 glycosylation Effects 0.000 claims 1
- 238000006206 glycosylation reaction Methods 0.000 claims 1
- 230000009851 immunogenic response Effects 0.000 claims 1
- 210000003734 kidney Anatomy 0.000 claims 1
- AEMBWNDIEFEPTH-UHFFFAOYSA-N n-tert-butyl-n-ethylnitrous amide Chemical compound CCN(N=O)C(C)(C)C AEMBWNDIEFEPTH-UHFFFAOYSA-N 0.000 claims 1
- 150000007523 nucleic acids Chemical group 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77947406P | 2006-03-06 | 2006-03-06 | |
| US84394506P | 2006-09-12 | 2006-09-12 | |
| PCT/US2007/005845 WO2007103447A2 (en) | 2006-03-06 | 2007-03-06 | A method for the preparation of recombinant human thrombin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009528843A JP2009528843A (ja) | 2009-08-13 |
| JP2009528843A5 true JP2009528843A5 (enExample) | 2010-04-22 |
Family
ID=38475538
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008558377A Pending JP2009528843A (ja) | 2006-03-06 | 2007-03-06 | 組換えヒトトロンビンおよびフィブリノゲンの調製法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20100159512A1 (enExample) |
| EP (2) | EP1996186A4 (enExample) |
| JP (1) | JP2009528843A (enExample) |
| CN (1) | CN101501216B (enExample) |
| AU (1) | AU2007223880A1 (enExample) |
| CA (1) | CA2644926A1 (enExample) |
| RU (1) | RU2008139428A (enExample) |
| WO (1) | WO2007103447A2 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2009223115B2 (en) | 2008-03-14 | 2015-09-24 | Humanzyme, Inc. | Recombinant production of authentic human proteins using human cell expression systems |
| EP3225252A1 (en) | 2008-05-02 | 2017-10-04 | Laboratoire Français du Fractionnement et des Biotechnologies | Treatment of bleeding with low half-life fibrinogen |
| NZ590871A (en) * | 2008-07-09 | 2012-07-27 | Profibrix Bv | Recombinant fibrinogen |
| FR2942232B1 (fr) * | 2009-02-19 | 2015-03-13 | Lfb Biotechnologies | Moyens pour la purification d'une proteine de la coagulation et procedes pour sa mise en oeuvre |
| US20120164111A1 (en) | 2009-04-14 | 2012-06-28 | Kurt Osther | Novel post-translational fibrinogen variants |
| PL2624859T3 (pl) * | 2010-10-06 | 2017-09-29 | Medimmune Limited | Czynnik ii samodzielnie lub w skojarzeniu z dalszymi czynnikami do leczenia zaburzeń hemostazy powiązanych z koagulopatią z rozcieńczenia |
| JP5839810B2 (ja) | 2011-03-03 | 2016-01-06 | 日本製粉株式会社 | フィブリノゲンを産生するトランスジェニックカイコ |
| CN102690803B (zh) * | 2011-03-24 | 2015-04-29 | 苏州泽璟生物制药有限公司 | 一种重组人凝血酶在动物细胞内的高效表达和生产方法 |
| EP2556842A1 (en) | 2011-08-11 | 2013-02-13 | Bioftalmik, S.L. | Composition in the form of film comprising fibrinogen and a fibrinogen activator and the applications thereof |
| HK1199908A1 (en) | 2011-09-06 | 2015-07-24 | Medimmune, Llc | Methods for processing coagulation factors |
| WO2014115087A2 (en) * | 2013-01-22 | 2014-07-31 | Cencor Biotech Ltd. | A method for the preparation of recombinant human prothrombin and fibrinogen |
| EP3274367A1 (en) * | 2015-03-23 | 2018-01-31 | Dana Genetic A/S | Recombinant soluble human tissue factor, method of its production and uses thereof |
| WO2016176440A2 (en) * | 2015-04-28 | 2016-11-03 | Saint Louis University | Thrombin-thrombomodulin fusion proteins as protein c activators |
| WO2017189943A1 (en) * | 2016-04-28 | 2017-11-02 | Saint Louis University | Thrombin-thrombomodulin fusion proteins as a powerful anticoagulant |
| BR102017004788B1 (pt) * | 2017-03-09 | 2021-03-23 | Instituto De Biologia Molecular Do Paraná - Ibmp. | Método de produção de cola de fibrina de origem recombinante |
| EP3618853B1 (en) * | 2018-04-24 | 2020-09-09 | Fibriant B.V. | Fibrinogen gamma prime variants for use in treating an infection |
| JP2025519280A (ja) | 2022-05-17 | 2025-06-25 | ユリウス－マキシミリアンズ－ユニヴァーシタエト ビュルツブルク | 手術創ケア用のフィブリンシーラントのための新規組換えフィブリノーゲンバリアント |
| CN116333094B (zh) * | 2023-02-04 | 2024-03-29 | 山东多美康生物医药有限公司 | 一种重组人源化I型胶原蛋白α1及表达载体和应用 |
| CN116218864B (zh) * | 2023-04-10 | 2024-01-09 | 山东多美康生物医药有限公司 | 一种重组Ⅲ型人源化胶原蛋白α1及其表达载体和应用 |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US722366A (en) | 1901-09-09 | 1903-03-10 | Lars Peter Larsen | Regenerative apparatus for the simultaneous warming and cooling of milk. |
| ATE20824T1 (de) | 1981-06-25 | 1986-08-15 | Serapharm Gmbh & Co Kg | Angereichertes plasmaderivat zur unterstuetzung von wundverschluss und wundheilung. |
| US4442655A (en) | 1981-06-25 | 1984-04-17 | Serapharm Michael Stroetmann | Fibrinogen-containing dry preparation, manufacture and use thereof |
| US4546082A (en) | 1982-06-17 | 1985-10-08 | Regents Of The Univ. Of California | E. coli/Saccharomyces cerevisiae plasmid cloning vector containing the alpha-factor gene for secretion and processing of hybrid proteins |
| US4713339A (en) | 1983-01-19 | 1987-12-15 | Genentech, Inc. | Polycistronic expression vector construction |
| US4870008A (en) | 1983-08-12 | 1989-09-26 | Chiron Corporation | Secretory expression in eukaryotes |
| US4613572A (en) | 1983-08-15 | 1986-09-23 | Kansas State University Research Foundation | Yeast BAR1 gene plasmid |
| US4931373A (en) | 1984-05-25 | 1990-06-05 | Zymogenetics, Inc. | Stable DNA constructs for expression of α-1 antitrypsin |
| EP0188555A4 (en) | 1984-07-09 | 1988-04-18 | Integrated Genetics Inc | YEAST CLONING VEHICLE. |
| JPS6144825A (ja) | 1984-08-09 | 1986-03-04 | Unitika Ltd | 止血剤 |
| EP0243465A1 (en) | 1985-10-25 | 1987-11-04 | Vivian L. Mackay | Method of using bar1 for secreting foreign proteins |
| US4965203A (en) | 1987-01-28 | 1990-10-23 | Warner-Lambert Company | Purified thrombin preparations |
| CZ333492A3 (en) * | 1991-11-12 | 1993-09-15 | Lilly Co Eli | Dipeptide of l-azetidine-2-carboxylic acids and l-argininaldehyde, process of its preparation and pharmaceutical preparation in which said dipeptide is comprised |
| US5572692A (en) | 1991-12-24 | 1996-11-05 | Intel Corporation | Memory configuration decoding system having automatic row base address generation mechanism for variable memory devices with row access interleaving |
| US5527692A (en) | 1991-12-31 | 1996-06-18 | Zymogenetics, Inc. | Methods for producing thrombin |
| JP3404038B2 (ja) | 1991-12-31 | 2003-05-06 | ザイモジェネティクス，インコーポレイティド | トロンビンの製造方法 |
| IL102929A (en) * | 1992-08-24 | 1996-11-14 | Interpharm Lab Ltd | Serum-free medium for mammalian cells |
| US5968817A (en) * | 1993-03-15 | 1999-10-19 | The Scripps Research Institute | DNA encoding serotonin receptors |
| SE9301916D0 (sv) * | 1993-06-03 | 1993-06-03 | Ab Astra | New peptides derivatives |
| EP0728210B1 (en) * | 1993-11-12 | 2005-04-13 | Gilead Sciences, Inc. | Thrombin mutants |
| US5639940A (en) | 1994-03-03 | 1997-06-17 | Pharmaceutical Proteins Ltd. | Production of fibrinogen in transgenic animals |
| DE19605126A1 (de) * | 1996-02-12 | 1997-08-14 | Basf Ag | Thrombinmuteine als Antidot für Thrombininhibitoren |
| US6037457A (en) | 1997-01-31 | 2000-03-14 | The University Of North Carolina At Chapel Hill | Method for recombinant fibrinogen production |
| US6780411B2 (en) | 1998-05-01 | 2004-08-24 | Zymogenetics, Inc. | Tissue sealant compositions |
| AT409379B (de) * | 1999-06-02 | 2002-07-25 | Baxter Ag | Medium zur protein- und serumfreien kultivierung von zellen |
| CA2446185C (en) * | 2001-05-07 | 2013-06-18 | National Research Council Of Canada | Enhanced production of recombinant proteins by transient transfection of suspension-growing mammalian cells |
| CA2452767C (en) * | 2001-07-06 | 2013-03-19 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Genetic recombinant ecarin and process for preparing the same |
| KR20040032147A (ko) * | 2001-07-06 | 2004-04-14 | 자이단호진 가가쿠오요비겟세이료호겐쿠쇼 | 유전자 재조합 기술에 의한 인간 트롬빈 제조 방법 |
| WO2003052059A2 (en) * | 2001-12-14 | 2003-06-26 | Eli Lilly And Company | Recombinant bovine thrombin |
| WO2004007714A1 (ja) * | 2002-07-17 | 2004-01-22 | Asahi Kasei Pharma Corporation | ヒトプロトロンビン類似体およびヒトメゾトロンビン類似体 |
| JP3994159B2 (ja) * | 2003-03-24 | 2007-10-17 | 農林水産省動物医薬品検査所長 | 動物由来成分無添加培養液およびそれを用いる細胞系の作出方法 |
| GB0324044D0 (en) * | 2003-10-14 | 2003-11-19 | Astrazeneca Ab | Protein |
| EP1676911B1 (en) * | 2003-10-24 | 2010-04-21 | Juridical Foundation, The Chemo-Sero-Therapeutic Research Institute | Novel recombinant animal cells with high protein production, method of constructing the same and method of mass protein production using the same |
| MX2007001294A (es) * | 2004-08-17 | 2008-03-04 | Zlb Behring Gmbh | Polipeptidos modificados que dependen de vitamina k. |
| WO2008008862A2 (en) * | 2006-07-11 | 2008-01-17 | Invitrogen Corporation | Proteome standards for mass spectrometry |
-
2007
- 2007-03-06 CA CA002644926A patent/CA2644926A1/en not_active Abandoned
- 2007-03-06 AU AU2007223880A patent/AU2007223880A1/en not_active Abandoned
- 2007-03-06 US US12/281,877 patent/US20100159512A1/en not_active Abandoned
- 2007-03-06 CN CN2007800143376A patent/CN101501216B/zh not_active Expired - Fee Related
- 2007-03-06 JP JP2008558377A patent/JP2009528843A/ja active Pending
- 2007-03-06 EP EP20070752537 patent/EP1996186A4/en not_active Withdrawn
- 2007-03-06 WO PCT/US2007/005845 patent/WO2007103447A2/en not_active Ceased
- 2007-03-06 RU RU2008139428/13A patent/RU2008139428A/ru unknown
- 2007-03-06 EP EP11181186A patent/EP2407561A3/en not_active Withdrawn
-
2012
- 2012-03-30 US US13/435,778 patent/US20130017591A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009528843A5 (enExample) | ||
| RU2008139428A (ru) | Способ получения рекомбинантного тромбина и фибриногена человека | |
| NZ592082A (en) | Promoters for recombinant viral expression | |
| FI3313991T3 (fi) | Muunnettu tekijä IX sekä koostumukset, menetelmät ja käytöt geeninsiirtoa varten soluihin, elimiin ja kudoksiin | |
| CN102558309B (zh) | 一对转录激活子样效应因子核酸酶及其编码基因与应用 | |
| JP2010539926A5 (enExample) | ||
| JP2018514190A5 (enExample) | ||
| JP2015521465A5 (enExample) | ||
| JP2013027391A5 (enExample) | ||
| JP2012520085A5 (enExample) | ||
| JP2019530466A5 (enExample) | ||
| JP2010518833A5 (enExample) | ||
| WO2012172277A4 (en) | Simian adenovirus and hybrid adenoviral vectors | |
| JP2013519365A5 (enExample) | ||
| JP2004267216A5 (enExample) | ||
| NZ602351A (en) | Axmi-115, axmi-113, axmi-005, axmi-163 and axmi-184 : vip3a insecticidal proteins from bacillus thuringiensis and methods for their use | |
| NZ596823A (en) | Swine influenza hemagglutinin variants | |
| JP2009529856A5 (enExample) | ||
| JP2013507935A5 (enExample) | ||
| GB201201178D0 (en) | Novel enzymes | |
| RU2011142793A (ru) | Полученная из микроорганизма протеаза усовершенствованного типа, обеспечивающая свертывание молока | |
| JP2016501515A5 (enExample) | ||
| MX2020005724A (es) | Variantes de alfa-amilasa y polinucleotidos que codifican las mismas. | |
| RU2010119028A (ru) | Удф-глюкуронилтрансфераза и кодирующий ее полинуклеотид | |
| CN113980917A (zh) | 一种慢病毒溶解缓冲液及其应用 |